PACT (PKR activating protein) / PRKRA Antibody

About the Target

PACT (PKR activating protein)/PRKRA, also known as (Protein Activator of PKR) is a 313-amino acid cellular protein characterized by three conserved double-stranded RNA-binding motifs (dsRBMs), of which dsRBMs 1 and 2 bind dsRNA, while domain 3 is crucial for activating the double-stranded RNA-activated protein kinase (PKR) in vitro, even in the absence of dsRNA. PACT is widely expressed, with high levels in the brain and immune cells, and its expression is upregulated by factors like proinflammatory cytokines, stress conditions (oxidative or hyperosmotic), and viral infections. Depending on the literature source, PRKRA may also be discussed as PACT (PKR activating protein) / PRKRA and PACT.

Reported cellular context includes cytoplasm, which can matter when signal is compared across treatments or changing cell states. Following PRKRA across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

PRKRA is commonly interpreted in the context of immunology and infectious disease research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• signal enrichment within cytoplasm relative to the broader cellular background
• context differences tied to immune-cell state, activation, or lineage composition
• host-response changes during infection or pathogen-associated stimulation
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for PRKRA. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in PRKRA reflect biology rather than handling. When interpreting PRKRA, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep PRKRA trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.